Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Other Working Capital | 835,000 | -345,000 | -426,000 | -350,000 | 41,000 |
| Other Operating Activity | 4,299,000 | 3,731,000 | 4,139,000 | 3,257,000 | 3,342,000 |
| Operating Cash Flow | $5,134,000 | $3,386,000 | $3,713,000 | $2,907,000 | $3,383,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -686,000 | -650,000 | -428,000 | -706,000 | -417,000 |
| Net Acquisitions | -338,000 | -267,000 | -362,000 | -274,000 | -281,000 |
| Purchase Of Investment | -30,000 | -188,000 | 0 | 0 | -29,000 |
| Sale Of Investment | 7,000 | 114,000 | 1,000 | -32,000 | 47,000 |
| Purchase Sale Intangibles | -1,039,000 | -1,178,000 | -531,000 | -231,000 | -909,000 |
| Other Investing Activity | 86,000 | 147,000 | 76,000 | 78,000 | 107,000 |
| Investing Cash Flow | $-2,001,000 | $-2,108,000 | $-1,253,000 | $-1,181,000 | $-1,514,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -352,000 | 635,000 | 1,099,000 | -603,000 | -1,931,000 |
| Debt Issued | 0 | 9,000 | 0 | 0 | 1,516,000 |
| Debt Repayment | -4,000 | -12,000 | -4,000 | -5,000 | -2,004,000 |
| Common Stock Issued | -14,000 | 1,000 | -478,000 | 23,000 | -77,000 |
| Dividend Paid | -1,611,000 | -10,000 | -3,347,000 | -3,000 | -1,576,000 |
| Other Financing Activity | -92,000 | -105,000 | 23,000 | -83,000 | -59,000 |
| Financing Cash Flow | $-2,073,000 | $518,000 | $-2,707,000 | $-671,000 | $-4,131,000 |
| Exchange Rate Effect | -12,000 | 29,000 | 25,000 | -61,000 | 20,000 |
| Beginning Cash Position | 7,032,000 | 5,207,000 | 5,429,000 | 4,435,000 | 6,677,000 |
| End Cash Position | 8,080,000 | 7,032,000 | 5,207,000 | 5,429,000 | 4,435,000 |
| Net Cash Flow | $1,060,000 | $1,796,000 | $-247,000 | $1,055,000 | $-2,262,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,134,000 | 3,386,000 | 3,713,000 | 2,907,000 | 3,383,000 |
| Capital Expenditure | -1,726,000 | -1,923,000 | -969,000 | -955,000 | -1,358,000 |
| Free Cash Flow | 3,408,000 | 1,463,000 | 2,744,000 | 1,952,000 | 2,025,000 |